<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02993588</url>
  </required_header>
  <id_info>
    <org_study_id>Melatonin RCT</org_study_id>
    <nct_id>NCT02993588</nct_id>
  </id_info>
  <brief_title>Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders</brief_title>
  <official_title>Impact of Melatonin Adjuvant Therapy on IVF/ICSI Outcomes in Prospective Poor Responders: A Double-blind, Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the impact of melatonin administration on in
      vitro fertilization (IVF/ICSI) outcomes namely the total number and quality of the oocytes
      and embryos in the prospective poor responders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective poor responders have been associated with lower number and poorer oocyte
      quality. Melatonin is suggested to have antioxidative effects which may contribute to
      improving the IVF/ICSI outcomes in this group of patients who expected to have poor outcomes.
      However, the expected beneficial effects of melatonin have not yet been investigated. The
      purpose of this study is to investigate the impact of melatonin administration on IVF/ICSI
      outcomes namely the total number and quality of the oocytes and embryos in the prospective
      poor responders. A randomized, double-blinded, placebo-controlled study is used to
      investigate the impact of melatonin on the IVF/ICSI outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total number of retrieved mature oocytes</measure>
    <time_frame>On the day of oocyte retrieval procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>In Vitro Fertilization</condition>
  <condition>Poor Ovarian Response</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Melatonin 6 mg tablet once daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablet once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>Melatonin 6 mg tablet once daily</description>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>one tablet once daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prospective poor responder with AMH &lt; 1 ng/ml and AFC &lt; 8 (in both ovaries).

        Exclusion Criteria:

          -  Severe male factor infertility.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osama Abdalmageed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women health center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Osama Abdalmageed, MD</last_name>
    <phone>1007972027</phone>
    <email>drosamast1981@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Osama Abdalmageed, MD</last_name>
    <phone>882102204</phone>
    <email>drosamast1981@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Osama Abdalmageed</name>
      <address>
        <city>Assiut</city>
        <state>Non-US/Non-Canadian</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama Abdalmageed, MD</last_name>
      <phone>1007972027</phone>
      <email>drosamast1981@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Osama Abdalmageed</last_name>
      <phone>1007972027</phone>
      <email>drosamast1981@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Osama Abdalmageed</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama Abdalmageed</last_name>
      <phone>1007972027</phone>
      <email>drosamast@yahoo.com.au</email>
    </contact>
    <contact_backup>
      <last_name>Osama Abdalmageed</last_name>
      <phone>1007972027</phone>
      <phone_ext>Abdalmageed</phone_ext>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Fernando S, Rombauts L. Melatonin: shedding light on infertility?--A review of the recent literature. J Ovarian Res. 2014 Oct 21;7:98. doi: 10.1186/s13048-014-0098-y. Review.</citation>
    <PMID>25330986</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2016</study_first_submitted>
  <study_first_submitted_qc>December 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2016</study_first_posted>
  <last_update_submitted>December 14, 2016</last_update_submitted>
  <last_update_submitted_qc>December 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Osama Saber Thabet Abdalmageed</investigator_full_name>
    <investigator_title>Lecturer of OBGYN, Women Health Hospital, Assiut Univerisity</investigator_title>
  </responsible_party>
  <keyword>Melatonin</keyword>
  <keyword>IVF/ICSI</keyword>
  <keyword>Poor ovarian response</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data will be kept with the study team only and it is not allowed by our institution regulations to share the data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

